What was Star Health's Q4 financial performance?

Star Health and Allied Insurance Company reported a Q4 profit surge of over 218 times to ₹111.3 crore, alongside steady operational growth.

How did Bandhan Bank perform in Q4?

Bandhan Bank's Q4 profit jumped 68% year-on-year to ₹534.1 crore, although core income growth was modest.

Did Solara Active Pharma Sciences receive any regulatory updates?

Yes, Solara Active Pharma Sciences' Ibuprofen manufacturing facility in Puducherry successfully cleared an unannounced inspection by the U.S. Food and Drug Administration.

Home / Business and Economy / Star Health Soars: Q4 Profit Jumps 218x!

Star Health Soars: Q4 Profit Jumps 218x!

29 Apr

•

Summary

Star Health profit surged over 218 times to ₹111.3 crore in Q4.
Bandhan Bank Q4 profit jumped 68% to ₹534.1 crore.
Solara Active Pharma's facility cleared a US FDA inspection.

Star Health Soars: Q4 Profit Jumps 218x!

Several stocks were in focus on April 28 due to corporate developments and earnings. Star Health and Allied Insurance Company shares rallied nearly 9 percent, hitting a 52-week high, as its Q4 profit surged over 218 times to ₹111.3 crore. The insurer also reported steady operational growth.

In the banking sector, Bandhan Bank share price rose 9 percent after its Q4 profit jumped 68% to ₹534.1 crore, though net interest income saw modest growth. CEAT and Motherson Sumi Wiring India also saw gains following positive revenue and profit reports. Greenply Industries shares jumped 12 percent on strong Q4 profit and revenue increases.